Andersen CL - Search Results

1

[Eosinophilia--pathogenesis, classification and therapy].

Andersen CL, Vestergaard H, Nørgaard P, Felding P, Pallisgaard N, Rasmussen IH, Hasselbalch HC, Bjerrum OW. Andersen CL, et al. Ugeskr Laeger. 2009 Nov 2;171(45):3256-62. Ugeskr Laeger. 2009. PMID: 19887055 Review. Danish.

2

[Discontinuation of antidepressant serotonergic antidepressant].

Andersen CL, Videbech P. Andersen CL, et al. Ugeskr Laeger. 2010 Jan 25;172(4):296-8. Ugeskr Laeger. 2010. PMID: 20105399 Danish.

3

Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms.

Andersen CL, Hasselbalch H, Grønbæk K. Andersen CL, et al. Leuk Res. 2012 Apr;36(4):485-7. doi: 10.1016/j.leukres.2011.11.018. Epub 2011 Dec 15. Leuk Res. 2012. PMID: 22177454

4

Systemic mastocytosis--a systematic review.

Andersen CL, Kristensen TK, Severinsen MT, Møller MB, Vestergaard H, Bergmann OJ, Hasselbalch HC, Bjerrum OW. Andersen CL, et al. Dan Med J. 2012 Mar;59(3):A4397. Dan Med J. 2012. PMID: 22381091 Free article. Review.

5

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.

Andersen CL, McMullin MF, Ejerblad E, Zweegman S, Harrison C, Fernandes S, Bareford D, Knapper S, Samuelsson J, Löfvenberg E, Linder O, Andreasson B, Ahlstrand E, Jensen MK, Bjerrum OW, Vestergaard H, Larsen H, Klausen TW, Mourits-Andersen T, Hasselbalch HC. Andersen CL, et al. Br J Haematol. 2013 Aug;162(4):498-508. doi: 10.1111/bjh.12416. Epub 2013 Jun 11. Br J Haematol. 2013. PMID: 23758082 Free article. Clinical Trial.

6

Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death.

Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, de Fine Olivarius N, Bjerrum OW. Andersen CL, et al. Am J Hematol. 2013 Oct;88(10):843-7. doi: 10.1002/ajh.23515. Epub 2013 Aug 1. Am J Hematol. 2013. PMID: 23765950 Free article. Clinical Trial.

7

Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on The Copenhagen Primary Care Differential Count (CopDiff) Database.

Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, Olivarius Nde F, Bjerrum OW. Andersen CL, et al. Acta Oncol. 2013 Dec 20. doi: 10.3109/0284186X.2013.866270. Epub 2013 Dec 20. Acta Oncol. 2013. PMID: 24358991 Retracted.

8

Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones.

Andersen CL, Asmar F, Klausen T, Hasselbalch H, Grønbæk K. Andersen CL, et al. Leuk Res Rep. 2012 Dec 8;2(1):1-3. doi: 10.1016/j.lrr.2012.10.002. eCollection 2012. Leuk Res Rep. 2012. PMID: 24371765 Free PMC article.

9

A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis.

Andersen CL, Mortensen NB, Klausen TW, Vestergaard H, Bjerrum OW, Hasselbalch HC. Andersen CL, et al. Haematologica. 2014 Jan;99(1):e5-7. doi: 10.3324/haematol.2013.096669. Haematologica. 2014. PMID: 24425692 Free PMC article. Clinical Trial. No abstract available.

10

The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation.

Mortensen KB, Gerds TA, Bjerrum OW, Lindmark A, Sengeløv H, Andersen CL. Mortensen KB, et al. Among authors: andersen cl. Leuk Res. 2014 Mar;38(3):334-9. doi: 10.1016/j.leukres.2013.12.009. Epub 2013 Dec 24. Leuk Res. 2014. PMID: 24439053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page